Top
FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
NPR News ·
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.
(Image credit: Maddie Meyer)
Originally published by
NPR News
Aggregated from a public feed. Read the original at the source for the publisher's full presentation.
View original on npr.org- 01Police say more than 150 bodies recovered after flash flood on Nepal-Tibet border with hundreds still missing – latest
- 02Final witness in Lindsay Clancy trial says he doesn’t believe she heard a voice during killings
- 03Burnham calls summit of Welsh, Scottish and Northern Irish first ministers
- 04Woman who died in fire with niece, 7, was 'beautiful soul', mother tells BBC